Learn
The company was pursuing several psychedelic business strategies, including synthesizing ibogaine for researchers....
We unpack five of the most important psychedelic studies conducted in recent years as psychedelics become mainstream medicine....
Skip the drugs, and take a trip on the screen instead....
This week in psychedelic business news: Small Pharma prepares big DMT studies; Health Canada approves a psilocybin PTSD study....
Our resident Psychedelic Investor details five companies he thinks are in strong position to win the psychedelic medicine race....
After a disappointing microdosing study, Dr. Michiel van Elk says the trend is "just not that interesting."...
Elemental Advisors Inc. CEO Tim Collins paints a picture of the past, present, and future of the psychedelics market in...
A double-blinded, randomized, and placebo-controlled study compares the subjective and autonomic effects of both psychedelics....
This month's "Spotlight in Focus" features candid conversation with an opioid addict, and the director writes how psychedelic therapy can...